Recent Developments:
In February 2022, Kenya's Ministry of Health announced the launch of malaria and COVID-19 PCR diagnostic kits in a bid to boost timely detection and treatment of the two diseases. The kits will save the country and families from importation at a higher price.
In December 2019, Access Bio Inc. developed a ultra-sensitive P. falciparum malaria detection kit in collaboration with Global Good. It is five times more analytically sensitive in identifying histidine-rich protein 2 (HRP2) antigens than currently available uRDTs.
Malaria Diagnostics Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients